{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:46:04Z","timestamp":1792190764502,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","award":["204075-103"],"award-info":[{"award-number":["204075-103"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijpddr.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T02:18:45Z","timestamp":1472609925000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Assessing anti-T.\u00a0cruzi candidates in\u00a0vitro for sterile cidality"],"prefix":"10.1016","volume":"6","author":[{"given":"Monica","family":"Cal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Robert","family":"Ioset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthia A.","family":"F\u00fcgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"M\u00e4ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.08.003_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0035-9203(92)90156-7","article-title":"Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains","volume":"86","author":"Andrade","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/315743","article-title":"Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago","volume":"182","author":"Bahia-Oliveira","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpddr.2011.12.002","article-title":"Recent developments in sterol 14-demethylase inhibitors for Chagas disease","volume":"2","author":"Buckner","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib4","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0036-46652002000100006","article-title":"Long term evaluation of etiological treatment of Chagas disease with benznidazole","volume":"44","author":"Cancado","year":"2002","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ijpddr.2016.08.003_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J.\u00a0Biomol. Screen."},{"issue":"8","key":"10.1016\/j.ijpddr.2016.08.003_bib7","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00520-15","article-title":"The limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in\u00a0vivo imaging","volume":"59","author":"Fortes Francisco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.08.003_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pt.2014.11.004","article-title":"Match-making for posaconazole through systems thinking","volume":"31","author":"F\u00fcgi","year":"2015","journal-title":"Trends Parasitol."},{"issue":"5","key":"10.1016\/j.ijpddr.2016.08.003_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4269\/ajtmh.1983.32.960","article-title":"Ketoconazole protects against infection with Trypanosoma cruzi in a murine model","volume":"32","author":"McCabe","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"20","key":"10.1016\/j.ijpddr.2016.08.003_bib18","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib10","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"4","author":"Moraes","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1462-5822.2012.01764.x","article-title":"Mechanisms of Trypanosoma cruzi persistence in Chagas disease","volume":"14","author":"Nagajyothi","year":"2012","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib12","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1128\/AAC.00070-13","article-title":"In\u00a0vitro and in\u00a0vivo studies of the antiparasitic activity of sterol 14alpha-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi","volume":"57","author":"Soeiro Mde","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib13","series-title":"Annual Meeting of the American Society of Tropical Medicine and Hygiene E1224","article-title":"Results of proof-of-concept clinical trial in patients with chronic indeterminate Chagas disease","author":"Torrico","year":"2013"},{"issue":"7","key":"10.1016\/j.ijpddr.2016.08.003_bib14","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.42.7.1771","article-title":"Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in\u00a0vitro and in\u00a0vivo studies","volume":"42","author":"Urbina","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J.\u00a0Eukaryot. Microbiol."},{"key":"10.1016\/j.ijpddr.2016.08.003_bib17","series-title":"Chagas Disease","author":"WHO","year":"2015"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:34Z","timestamp":1761921994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716300422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2211320716300422"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.08.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing anti-T.\u00a0cruzi candidates in\u00a0vitro for sterile cidality","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}